Wikipedia

Drug Enforcement Administration

(Redirected from D.E.A.)
"DEA" redirects here. For other uses, see DEA (disambiguation).
Not to be confused with the Food and Drug Administration.

The Drug Enforcement Administration (DEA) is a United States federal law enforcement agency under the U.S. Department of Justice tasked with combating illicit drug trafficking and distribution within the U.S. It is the lead agency for domestic enforcement of the Controlled Substances Act, sharing concurrent jurisdiction with the Federal Bureau of Investigation, the U.S. Immigration and Customs Enforcement, and U.S. Customs and Border Protection. However, the DEA has sole responsibility for coordinating and pursuing U.S. drug investigations both domestically and internationally.

Drug Enforcement Administration
Drug Enforcement Administration's seal
Drug Enforcement Administration's seal
DEA Special Agent badge
Flag of the DEA
Flag of the DEA
Agency overview
FormedJuly 1, 1973; 51 years ago (1973-07-01)
Preceding agencies
Employees9,848 (2021)
Annual budgetUS$ 3.28 billion (FY2021)[1]
Jurisdictional structure
Federal agency
(Operations jurisdiction)		United States
Operations jurisdictionUnited States
Legal jurisdictionNational
General nature
Operational structure
HeadquartersArlington County, Virginia, U.S.[2]
Special Agents4,649
Agency executives
Parent agencyUnited States Department of Justice
Website
dea.gov

It was established in 1973 as part of the U.S. government's war on drugs. The DEA has an intelligence unit that is also a member of the U.S. Intelligence Community. While the unit is part of the DEA chain-of-command, it also reports to the Director of National Intelligence. The DEA has been criticized for scheduling drugs that have medical uses, and for focusing on operations that allow it to seize money rather than those involving drugs that cause more harm.[citation needed]

History and mandate

edit

The Drug Enforcement Administration was established on July 1, 1973,[4] by Reorganization Plan No. 2 of 1973, signed by President Richard Nixon on July 28.[5] It proposed the creation of a single federal agency to enforce the federal drug laws as well as consolidate and coordinate the government's drug control activities. Congress accepted the proposal, as they were concerned with the growing availability of drugs.[6] As a result, the Bureau of Narcotics and Dangerous Drugs (BNDD), the Office of Drug Abuse Law Enforcement (ODALE); approximately 600 Special Agents of the Bureau of Customs, Customs Agency Service, and other federal offices merged to create the DEA.[7]

The DEA is the primary federal agency charged with implementing and enforcing the Controlled Substances Act (CSA), which is Title II of a larger Federal Act called the Comprehensive Drug Abuse Prevention and Control Act of 1970. The DEA is responsible for drugs listed in the CSA's five drug Schedules, categories that rank drugs by their potential for harm, and whether they have a medical use. The CSA seeks to ensure legitimate access to controlled pharmaceuticals, while preventing illicit use of controlled drugs. To these ends, the DEA implements two intersecting legal schemes created by the CSA, registration provisions for entities involved in legal activities, violations of which are not usually criminal offenses, and trafficking provisions for illegal activities, violations of which are criminal offenses.[8]

From the early 1970s, DEA headquarters was located at 1405 I ("Eye") Street NW in downtown Washington, D.C. With the overall growth of the agency in the 1980s (owing to the increased emphasis on federal drug law enforcement efforts) and concurrent growth in the headquarters staff, DEA began to search for a new headquarters location; locations in Arkansas, Mississippi and various abandoned military bases around the United States were considered. However, then-Attorney General Edwin Meese determined that the headquarters had to be located close to the Attorney General's office. Thus, in 1989, the headquarters relocated to 600–700 Army-Navy Drive in the Pentagon City area of Arlington County, Virginia, near the eponymous Metro station.[9]

 
Drug Enforcement Administration 25th Anniversary badge

On April 19, 1995, Timothy McVeigh carried out a terrorist attack on the Alfred P. Murrah Federal Building in Oklahoma City. He was targetting regional offices for the Federal Bureau of Investigation (FBI), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) and DEA, all of which had carried out raids that he viewed as unjustified intrusions on the rights of the people.[10] This attack caused the deaths of two DEA employees, one task force member and two contractors in the Oklahoma City bombing. Subsequently, the DEA headquarters complex was classified as a Level IV installation under United States federal building security standards, meaning it was to be considered a high-risk law enforcement target for terrorists.[11] Security measures include hydraulic steel roadplates to enforce standoff distance from the building, metal detectors and guard stations.[12]

In February 2003, the DEA established a Digital Evidence Laboratory within its Office of Forensic Sciences.[13]

Organization

edit
 
Map of the 21 DEA domestic field divisions: 1. Chicago, 2. Detroit, 3. Atlanta, 4. Dallas, 5. Denver, 6. Boston, 7. El Paso, 8. Houston, 9. Los Angeles, 10. Miami, 11. Newark, 12. New Orleans, 13. New York, 14. Philadelphia, 15. Phoenix, 16. San Diego, 17. San Francisco, 18. Seattle, 19. St. Louis, 20. Caribbean (San Juan, Puerto Rico), 21. Washington, D.C.

The DEA is headed by an Administrator of the Drug Enforcement Administration appointed by the president of the United States and confirmed by the U.S. Senate. The Administrator reports to the Attorney General through the Deputy Attorney General.[14] The administrator is assisted by a deputy administrator, the chief of operations, the chief inspector, and three assistant administrators (for the Operations Support, Intelligence, and Human Resources divisions). Other senior staff includes the chief financial officer and the chief counsel. The administrator and deputy administrator are the only presidentially appointed personnel in the DEA; all other DEA officials are career government employees. DEA's headquarters is located in Arlington County, Virginia, across from The Pentagon. It maintains its own DEA Academy located on the Marine Corps Base Quantico at Quantico, Virginia, alongside the FBI Academy. As of 2024, it maintains 241 domestic offices in 23 divisions, and 93 foreign offices in 69 countries.[15] With a budget exceeding $3 billion, DEA employs 10,169 people, including 4,924 Special Agents and 800 Intelligence Analysts.[citation needed][needs update] Becoming a Special Agent or Intelligence Analyst with the DEA is a competitive process.[citation needed]

c. 2015 its headquarters and the DEA Museum were in 503,776 square feet (46,802.3 m2) in Lincoln Place, a rented office building in Pentagon City in Arlington County, Virginia. In September 2018 this lease was scheduled to end. The General Services Administration (GSA), circa 2015, was checking to see where in Northern Virginia the DEA could be headquartered.[16] In 2018 the government of the United States extended the lease at Lincoln Place, now to expire circa 2033.[2] The DEA administration favored retaining the original location.[17]

Structure

edit
  • Administrator
    • Deputy Administrator
      • Human Resource Division
        • Career Board
        • Board of Professional Conduct
        • Office of Training
      • Operations Division
        • Aviation Division
        • Office of Operations Management
        • Special Operations Division
        • Office of Diversion Control
        • Office of Global Enforcement
        • Office of Financial Operations
      • Intelligence Division
      • Financial Management Division
        • Office of Acquisition and Relocation Management
        • Office of Finance
        • Office of Resource Management
      • Operational Support Division
        • Office of Administration
        • Office of Information System
        • Office of Forensic Science
        • Office of Investigative Technology
      • Inspection Division
        • Office of Inspections
        • Office of Professional Responsibility
        • Office of Security Programs
      • Field Divisions and Offices

Special agents

edit
 
DEA agents escort Colombian drug lord Miguel Rodríguez Orejuela after his extradition to the United States in 2005.

As of 2017, there were 4,650 special agents employed by the Drug Enforcement Administration. DEA agents' starting salary is $49,746–$55,483. After four years, the salary rises to above $92,592.[19]

After receiving a conditional offer of employment, recruits must then complete an 18-week rigorous training which includes lessons in firearms proficiency (including basic marksmanship), weapons safety, tactical shooting, and deadly-force decision training. To graduate, students must maintain an academic average of 80 percent on academic examinations, pass the firearms qualification test, successfully demonstrate leadership and sound decision-making in practical scenarios, and pass rigorous physical-task tests. Upon graduation, recruits earn the title of DEA Special Agent.

The DEA excludes from consideration job applicants who have a history of any use of narcotics or illicit drugs.[citation needed] Investigation usually includes a polygraph test for special-agent, diversion-investigator, and intelligence research specialist positions.

Applicants who are found, through investigation or personal admission, to have experimented with or used narcotics or dangerous drugs, except those medically prescribed, will not be considered for employment with the Drug Enforcement Administration (DEA). Exceptions to this policy may be made for applicants who admit to limited youthful and experimental use of marijuana. Such applicants may be considered for employment if there is no evidence of regular, confirmed usage and the full-field background investigation and results of the other steps in the process are otherwise favorable.[20]

The DEA's relatively firm stance on this issue contrasts with that of the Federal Bureau of Investigation, which in 2005 considered relaxing its hiring policy relevant to individual drug-use history.[21]

Aviation Division

edit
 
DEA Aviation Division logo

The DEA Aviation Division or Office of Aviation Operations (OA) (formerly Aviation Section) is an airborne division based in Perot Field Fort Worth Alliance Airport, Texas. The current OA fleet consists of 106 aircraft and 124 DEA pilots.[22]

The DEA shares a communications system with the Department of Defense for communication with state and regional enforcement independent of the Department of Justice and police information systems and is coordinated by an information command center called the El Paso Intelligence Center (EPIC) near El Paso, Texas.

Special Response Teams

edit
 
DEA agents in MultiCam uniform burning hashish seized in Operation Albatross in Afghanistan, 2007

Rapid Response Teams (RRT), previously known as Foreign-Deployed Advisory and Support Teams (FAST), were decommissioned by DEA Acting Administrator Chuck Rosenburg in March 2017 via memorandum. A need for domestic high-risk service teams led to the hybrid creation of specialized tactical units residing within various geographical regions throughout the United States.

DEA officially created and standardized its Special Response Team (SRT) program in 2016. The SRT was designed as a stop-gap between tactical operations conducted by field agents and those necessitating specialized tactics as a result of elevated risks. SRT operators are highly trained in various weapons systems and entry tactics/maneuvers. Because of the clandestine nature of the DEA mission, SRT training protocols and activation requirements are highly sensitive and not available to the public. Some of the SRT missions consist of high-risk arrests, vehicle assaults, air assault/infiltration, specialized surveillance, custody of high-profile individuals, dignitary and witness protection, tactical surveillance and interdiction, advanced breaching, tactical training to other police units, and urban and rural fugitive searches. Covertly located throughout the nation, DEA SRT teams are available to respond to practically any CONUS geographical area with little to no preparation or notification. The DEA SRT has been involved in several high-profile operations in recent years, however, DEA involvement is often not publicized due to operational and intelligence considerations. Considered one of the most covert outfits in federal law enforcement, very little is known about DEA SRT capabilities and its operator selection process.

In the past, DEA had other tactical teams like the High-risk Entry Apprehension Teams (HEAT) in some Field Divisions, and Operation Snowcap Teams (predecessor of FAST). The teams administered by the Mobile Enforcement Section, the Mobile Enforcement Teams (MET), and Regional Enforcement Teams (RET), were mobile investigative units intended to deploy resources to state and local agencies (MET) or DEA Field Divisions (RET) in need of assistance with a particular investigation or trafficking group. These programs ended in the early 2000s.

Special Operations Division

edit

The DEA Special Operations Division (SOD) is a division within the DEA, which forwards information from wiretaps, intercepts, and databases from various sources to federal agents and local law enforcement officials. The SOD came under scrutiny following the 2010s global surveillance disclosures.[23]

Domestic Cannabis Eradication/Suppression Program

edit

The Domestic Cannabis Eradication/Suppression Program (DCE/SP) began funding eradication programs in Hawaii and California in 1979. The program rapidly expanded to include programs in 25 states by 1982. By 1985, all 50 states were participating in the DCE/SP.[24] In 2015, the DCE/SP was responsible for the eradication of 3,932,201 cultivated outdoor cannabis plants and 325,019 indoor plants for a total of 4,257,220 marijuana plants. In addition, the DCE/SP accounted for 6,278 arrests and the seizure in excess of $29.7 million of cultivator assets.[25]

In 2014, the DEA spent $73,000 to eradicate marijuana plants in Utah, though they did not find a single marijuana plant.[26] Federal documents obtained by journalist Drew Atkins detail the DEA's continuing efforts to spend upwards of $14 million per year to completely eradicate marijuana within the United States despite the government funding allocation reports showing that the Marijuana Eradication Program often leads to the discovery of no marijuana plants.[27] This prompted twelve members of Congress to push for the elimination of the program and use the money instead to fund domestic-violence prevention and deficit-reduction programs.[28]

Budget

edit

In 2018, the DEA budget was $2.086 billion.[29] $445 million was spent on international enforcement and $1.627 billion was spent on domestic enforcement.

  • Breaking foreign and domestic sources of supply ($1.0149 billion) via domestic cannabis eradication/suppression; domestic enforcement; research, engineering, and technical operations; the Foreign Cooperative Investigations Program; intelligence operations (financial intelligence, operational intelligence, strategic intelligence, and the El Paso Intelligence Center); and drug and chemical diversion control.
  • Reduction of drug-related crime and violence ($181.8 million) funding state and local teams and mobile enforcement teams.
  • Demand reduction ($3.3 million) via anti-legalization education, training for law enforcement personnel, youth programs, support for community-based coalitions, and sports drug awareness programs.

Firearms

edit

DEA agents' primary service weapons are the Glock 17 and Glock 19, Remington 870 12-gauge shotgun, and Rock River Arms LAR-15 semi-automatic carbine in 5.56×45mm NATO. Agents may also qualify to carry a firearm listed on an authorized carry list maintained and updated by the Firearms Training Unit (FTU), Quantico, Virginia.

Special Agents may qualify with their own personally-owned handguns, rifle, and shotgun, and certain handguns are allowed to be used with permission from the FTU. Agents are required to attend tactical and firearms proficiency training quarterly, and to qualify with their handguns twice per year. The DEA has one of the most challenging handgun qualification courses in all of the federal law enforcement. Failure to achieve a passing qualification score is the reason for most Academy dismissals and special agents in the field may have their authority to carry a firearm revoked for failure to qualify.

Basic Agent Trainees (BATs) who fail the initial pistol qualification course of fire are placed in a remedial program to receive additional training. In remedial training, BATs receive five extra two-hour range sessions, for a total of 10 more hours of live fire training on their issued sidearm, to further aid them in helping pass the pistol qualification. After passing their pistol qualification, Basic Agent Trainees move on to receive formal training on the DEA's standard-issue long guns and will continue to frequently shoot the agency-issued sidearms that they have already qualified on. In all, BATs receive a total of 32 firearms training sessions, when combining classroom instruction, gear issue, and pistol, rifle, and shotgun live fire training at the DEA Academy. They will shoot the qualification courses for all three weapons systems during their initial training but must pass their final qualification attempts only on their Glock pistols to become a Special Agent.

 
Two DEA agents in a shoot house exercise

Agents are trained to use shoulder-fired weapons, such as the Rock River LAR-15, adopted in 2004, and the LWRC M6A2, the standard carbine of DEA. The Colt 9mm SMG was previously issued, but no longer in service. Agents are required to complete a two-day (16-hour) proficiency course to carry a shoulder weapon on enforcement operations. They may carry a Rock River LAR-15 or LWRC carbine as authorized, personally-owned weapons, provided they meet the same training and proficiency standards.

Impact on the drug trade

edit
See also: Illegal drug trade

In 2005, the DEA seized a reported $1.4 billion in drug trade related assets and $477 million worth of drugs.[30] According to the White House's Office of Drug Control Policy, the total value of all of the drugs sold in the U.S. is as much as $64 billion a year,[31] giving the DEA an efficiency rate of less than 1% at intercepting the flow of drugs into and within the United States. Critics of the DEA (including recipient of the Nobel Memorial Prize in Economic Sciences, Milton Friedman, prior to his death a member of Law Enforcement Against Prohibition) point out that demand for illegal drugs is inelastic; the people who are buying drugs will continue to buy them with little regard to price, often turning to crime to support expensive drug habits when the drug prices rise. One recent study by the DEA showed that the price of cocaine and methamphetamine is the highest it has ever been while the quality of both is at its lowest point ever.[32] This is contrary to a collection of data done by the Office of National Drug Control Policy, which states that purity of street drugs has increased, while price has decreased.[33][34][35] In contrast to the statistics presented by the DEA, the United States Department of Justice released data in 2003 showing that purity of methamphetamine was on the rise.[36]

Registration and licensing

edit
 
"Operation Somalia Express" was an 18-month investigation that included the coordinated takedown of a 44-member international narcotics-trafficking organization responsible for smuggling more than 25 tons of khat from the Horn of Africa to the United States.

The DEA has a registration system in place which authorizes anyone to manufacture, import, export, and distribute by filing DEA form 225 Archived November 8, 2015, at the Wayback Machine along with medical professionals, researchers and manufacturers access to "Schedule I" drugs, as well as Schedules 2, 3, 4 and 5. Authorized registrants apply for and, if granted, receive a "DEA number". An entity that has been issued a DEA number is authorized to manufacture (drug companies), distribute research, prescribe (doctors, pharmacists, nurse practitioners and physician assistants, etc.), or dispense (pharmacy) a controlled substance.

Diversion control system

edit

Many problems associated with substance use disorders are the result of legitimately manufactured controlled substances being diverted from their lawful purpose into the illicit drug traffic. Many of the analgesics, depressants and stimulants manufactured for legitimate medical use can often carry the potential for addiction. Therefore, those scheduled substances have been brought under legal control for prevention and population safety. The goal of controls is to ensure that these "controlled substances" are readily available for medical use while preventing their distribution for illicit distribution and non-medical use. This can be a difficult task, sometimes providing difficulty for legitimate patients and healthcare providers while circumventing illegal trade and consumption of scheduled drugs.

Under federal law, all businesses which manufacture or distribute controlled drugs, all health professionals entitled to dispense, administer or prescribe them, and all pharmacies entitled to fill prescriptions must register with the DEA. Registrants must comply with a series of regulatory requirements relating to drug security, records accountability, and adherence to standards.

All of these investigations are conducted by Diversion Investigators (DIs). DIs conduct investigations to uncover and investigate suspected sources of diversion and take appropriate civil and administrative actions. Prescription Database Management Programs (PDMP) aid and facilitate investigation and surveillance.[citation needed]

Fentanyl overdose crisis

edit

In 2019 and 2020, record overdoses from illicit fentanyl tablets or as a deadly adulterant in heroin have ravaged North America. An estimated 19,416 individuals died of a drug overdose in the United States in the first 3 months of 2020 compared with 16,682 in the same 3-month period in 2019; this trend was fueled by synthetic opioids (especially illicitly manufactured fentanyl and analogs). Furthermore, between May 2020 and April 2021, the estimated number of drug overdose deaths in the United States exceeded 100,000 over this time period, with 64.0% of deaths involving synthetic opioids other than methadone (the same illicitly manufactured fentanyls and analogs).[37] In contrast, Europe has seen a decrease from heroin overdoses, and a practical absence of illicit, synthetic opioids.

Fentanyl, originally developed in the 1970s by Janssen Pharmaceutica, is a potent anesthetic primarily used in hospital or hospice settings. In Europe, heroin is mainly supplied from Western Asia (from Afghanistan and neighboring countries), and less likely to be contaminated with fentanyl. In North America, there are now fewer deaths involving heroin than either meth or cocaine, a striking change that has taken place over the last two years as heroin has all but disappeared from some regions. Due to the absence of heroin from Asian sources, fentanyl-laced heroin powder or tablets have filled that void.[38]

In October 2021, the US reported another record in fentanyl deaths, as federal agencies were unable to stem the tide of illicit, synthetic drugs entering the US. Originally, introduced to replace much of the white powder heroin in the Eastern United States, the drug continues to move further west. Between July 2019–December 2020, illicitly manufactured fentanyl involved deaths increased sharply in midwestern (33.1%), southern (64.7%), and western (93.9%) jurisdictions.

MDMA DEA scheduling overturn

edit

In 1985 MDMA and its analogues were under review by the American government as a drug with a potential for addiction. During this time, several public hearings on the new drug were held by the DEA. Based on all of the evidence and facts presented at the time, the DEA's administrative law judge did not see MDMA and its analogues as being of large concern and recommended that they be placed in Schedule III. The DEA administrator, expressing concern for addictive potential, overruled the recommendation and ruled that MDMA be put in Schedule I, the Controlled Substances Act's most restrictive category.[39][40][41]

Rank structure

edit

The following is a listing of the rank structure found within the DEA (in ascending order):

  • Agents
  • Management
    • Assistant Administrator
    • Associate Deputy Administrator
    • Deputy Administrator
    • Principal Deputy Administrator
    • Chief of Staff
    • Administrator

Criticism and controversies

edit
See also: Criticism of the United States government § Criticism of agencies

The DEA has been criticized for placing highly restrictive schedules on a few drugs that researchers in the fields of pharmacology and medicine regard as having medical uses. Critics assert that some such decisions are motivated primarily by political factors stemming from the U.S. government's War on Drugs and that many benefits of such substances remain unrecognized due to the difficulty of conducting scientific research. A counterpoint to that criticism is that under the Controlled Substances Act it is the Department of Health and Human Services (through the Food and Drug Administration and the National Institute on Drug Abuse), not the DEA, which has the legal responsibility to make scientific and medical determinations with respect to drug scheduling; no drug can be scheduled if the Secretary of Health and Human Services recommends against it on a scientific or medical basis, and no drug can be placed in the most restrictive schedule (Schedule I) if DHHS finds that the drug has an accepted medical use. Jon Gettman's essay Science and the End of Marijuana Prohibition describes the DEA as "a fall guy to deflect responsibility from the key decision-makers" and opines, "HHS calls the shots when it comes to marijuana prohibition, and the cops at DEA and the general over at ONDCP take the heat."[citation needed]

The DEA is also criticized for focusing on the operations from which it can seize the most money,[42] namely the organized cross-border trafficking of marijuana. Some individuals contemplating the nature of the DEA's charter advise that, based on danger, the DEA should be most focused on cocaine. Others suggest that, based on opiate popularity, the DEA should focus much more on prescription opiates used recreationally, which critics contend comes first before users switch to heroin.

Practitioners who legally prescribe medicine however must possess a valid DEA license. According to federal law, the budget of the DEA Diversion Control Program is to be paid by these license fees. In 1984 a three-year license cost $25. In 2009 the fee for a three-year license was $551. Some have likened this approach to license fees unreasonable, "like making pilot licenses support the entire Federal Aviation Administration (FAA) budget." The renewal fee for 2020 as of October 1, 2020, is $888 for a three-year license.[43]

In 2005, the DEA estimated that it had over 4,000 informants without which they "could not effectively enforce the controlled substances laws of the United States."[44] To gather information, agents permitted their informants to buy and sell drugs, engage in Medicaid fraud rings, and other illicit acts.[44] Despite this, the DEA claims that they are "in compliance" with the rules for using informants to gather information about illicit activities.[44]

Costs

edit

The total budget of the DEA from 1972 to 2014, according to the agency website, was $50.6 billion. The agency had 11,055 employees in 2014. For the year 2014 the average cost per arrest made was $97,325.[45]

Civil liberties

edit

Others, such as former Republican congressman Ron Paul, the Cato Institute,[46] The Libertarian Party[47] and the Drug Policy Alliance[48] criticize the very existence of the DEA and the War on Drugs as both hostile, and contrary, to the concept of civil liberties by arguing that anybody should be free to put any substance they choose into their own bodies for any reason, particularly when legal drugs such as alcohol, tobacco and prescription drugs are also open to addiction, and that any harm caused by a drug user or addict to the general public is a case of conflicting civil rights. Recurrently, billions of dollars are spent yearly, focusing largely on criminal law and demand reduction campaigns, which has resulted in the imprisonment of thousands of U.S. citizens.[49] Demand for recreational drugs is somewhat static as the market for most illegal drugs has been saturated, forcing the cartels to expand their market to Europe and other areas than the United States.[citation needed] United States federal law registers cannabis as a Schedule I drug.[50]

Incarceration of Daniel Chong

edit
Main article: Incarceration of Daniel Chong

In April 2012 in San Diego, California, DEA agents detained a student, Daniel Chong, and left him locked in a holding room for five days. The cell contained no food, water or bathroom facilities.[51] When he was found, he had to be hospitalized for several days for a variety of medical problems. The incident touched off a national furor, resulting in several investigations. The incident has been described as a "Kafkaesque nightmare,"[52] a "debacle," and "one of the worst cases of its kind."[53] Chong subsequently sued the DEA; the government settled the suit for $4.1 million.[54]

Department of Justice Smart on Crime Program

edit

On August 12, 2013, at the American Bar Association's House of Delegates meeting, Attorney General Eric Holder announced the "Smart on Crime" program, which is "a sweeping initiative by the Justice Department that in effect renounces several decades of tough-on-crime anti-drug legislation and policies."[55][56] Holder said the program "will encourage U.S. attorneys to charge defendants only with crimes "for which the accompanying sentences are better suited to their individual conduct, rather than excessive prison terms more appropriate for violent criminals or drug kingpins..."[55][56] Running through Holder's statements, the increasing economic burden of over-incarceration was stressed.[55][56] As of August 2013, the Smart on Crime program is not a legislative initiative but an effort "limited to the DOJ's policy parameters."[55][56]

International events

edit

David Coleman Headley (born Daood Sayed Gilani, June 30, 1960) who was working as an informant for the U.S. Drug Enforcement Administration (DEA) simultaneously made periodic trips to Pakistan for LeT training and was one of the main conspirators in the 2008 Mumbai attacks. On January 24, 2013, Headley, then 52 years old, was sentenced by U.S. District Judge Harry Leinenweber of the United States District Court for the Northern District of Illinois in Chicago to 35 years in prison for his part in the 2008 Mumbai attacks, in which at least 164 victims (civilians and security personnel) and nine attackers were killed. Among the dead were 28 foreign nationals from 10 countries.[57][58][59][60][61] One attacker was captured.[58] The bodies of many of the dead hostages showed signs of torture or disfigurement.[62] A number of those killed were notable figures in business, media, and security services.[63][64][65]

The DEA was accused in 2005 by the Venezuelan government of collaborating with drug traffickers, after which President Hugo Chávez decided to end any collaboration with the agency. In 2007, after the U.S. State Department criticized Venezuela in its annual report on drug trafficking, the Venezuelan Minister of Justice reiterated the accusations: "A large quantity of drug shipments left the country through that organization. We were in the presence of a new drug cartel."[66] In his 1996 series of articles and subsequent 1999 book, both titled Dark Alliance, journalist Gary Webb asserts that the DEA helped harbor Nicaraguan drug traffickers. Notably, they allowed Oscar Danilo Blandón political asylum in the USA despite knowledge of his cocaine-trafficking organization.[67]

The government of Bolivia has also taken similar steps to ban the DEA from operating in the country. In September 2008, Bolivia drastically reduced diplomatic ties with the United States, withdrawing its ambassador from the US and expelling the US ambassador from Bolivia. This occurred soon after Bolivian president Evo Morales expelled all DEA agents from the country due to a revolt in the traditional coca-growing Chapare Province. The Bolivian government claimed that it could not protect the agents, and Morales further accused the agency of helping incite the violence, which claimed 30 lives. National agencies were to take over control of drug management.[68] Three years later, Bolivia and the US began to restore full diplomatic ties. However, Morales maintained that the DEA would remain unwelcome in the country, characterising it as an affront to Bolivia's "dignity and sovereignty".[69]

In the Netherlands, both the Dutch government and the DEA have been criticized for violations of Dutch sovereignty in drug investigations. According to Peter R. de Vries, a Dutch journalist present at the 2005 trial of Henk Orlando Rommy, the DEA has admitted to activities on Dutch soil. Earlier, then Minister of Justice Piet Hein Donner, had denied to the Dutch parliament that he had given permission to the DEA for any such activities, which would have been a requirement by Dutch law in order to allow foreign agents to act within the territory.[70]

The DEA conducted a covert operation over several years in which undercover operatives were sent to Venezuela to build drug-trafficking cases against Venezuela's leadership, including Nicholas Maduro. The plan was part of "Operation Money Badger", which the DEA and prosecutors in Miami created in 2013. It potentially breached Venezuelan and international law and therefore required the approval of the Sensitive Activity Review Committee, a secretive panel of senior State and Justice Department officials that oversees the most sensitive DEA cases involving tricky ethical, legal or foreign policy considerations.[71]

Following the Colombian peace process, which brought an end to the Colombian conflict between the Colombian government and the Revolutionary Armed Forces of Colombia (FARC–EP), the Special Jurisdiction for Peace found that the DEA had plotted with Colombian Attorney General Néstor Humberto Martínez to fabricate drug trafficking charges against Jesús Santrich, in a bid to jeopardize the peace agreement by inciting the FARC to take up arms again.[72]

Special Operations Division fabricated evidence trails

edit

In 2013, Reuters published a report about the DEA's Special Operations Division (SOD) stating that it conceals where an investigative trail about a suspect truly originates from and creates a parallel set of evidence given to prosecutors, judges, and defense lawyers. This DEA program mainly affects common criminals such as drug dealers. The concealment of evidence means the defendant is unaware of how his or her investigation began and will be unable to request a review of possible sources of exculpatory evidence. Exculpatory evidence may include biased witnesses, mistakes, or entrapment. Nancy Gertner, a former federal judge who had served from 1994 to 2011 and a Harvard Law School professor, stated that "It is one thing to create special rules for national security. Ordinary crime is entirely different. It sounds like they are phonying up investigations."[73] Andrew O'Hehir of Salon wrote that "It’s the first clear evidence that the “special rules” and disregard for constitutional law that have characterized the hunt for so-called terrorists have crept into the domestic criminal justice system on a significant scale."[74]

Cannabis rescheduling

edit

A 2014 report by the Multidisciplinary Association for Psychedelic Studies and the Drug Policy Alliance accuses the DEA of unfairly blocking the removal of cannabis from Schedule I. The report alleges that the methods employed by the DEA to achieve this include: delaying rescheduling petitions for years, overruling DEA administrative law judges, and systematically impeding scientific research.[75] The DEA continues to refuse the removal of cannabis from Schedule I despite wide-scale acceptance of the substance among the medical community, including 76% of doctors, for the treatment of various diseases.[76][77][78]

Domestic anti-drug advocacy

edit

The DEA, in addition to enforcement, also regularly engage in advocacy, specifically against rescheduling marijuana, by publishing policy-based papers on certain drugs. Some[who?] have criticized the DEA for using tax dollars in what they call an attempt to change public opinion, which they call an overreach from the scope of the agency's job of enforcement, and that by releasing such non-peer-reviewed reports is a transparent attempt to justify its own activities. They have claimed that since the DEA is not, by law, an advocacy group, but a legal enforcement group, that those press releases are tantamount to what they consider domestic propaganda.[citation needed]

Raids on medical marijuana dispensaries

edit
 
People protesting medical marijuana raids

The DEA has taken a particularly strong stance on enforcement of the Controlled Substances Act on persons and organizations acting within state laws that allow medical cannabis cultivation and distribution.[79] DEA agency executive Chuck Rosenberg has made negative statements against patients who use medical marijuana.[citation needed] Rosenberg has mentioned that he considers medical marijuana to be a "joke".[citation needed] As a reaction against the negative statements made by Rosenberg towards medical marijuana, an international online petition has been formed. More than 159,737 signatures have been gathered globally with the intention that Rosenberg be fired or forced to resign as head of DEA.[80]

"The people of California and the County of Santa Cruz have overwhelmingly supported the provision of medical marijuana for people who have serious illnesses," county Supervisor Mardi Wormhoudt told the San Francisco Chronicle. "These people (blocking the road) are people with AIDS and cancer and other grave illnesses. To attack these people, who work collectively and have never taken money for their work, is outrageous."[81][82]

As a result, the Wo/Men's Alliance for Medical Marijuana, with the City and County of Santa Cruz, had sued the DEA, Attorney General Michael Mukasey, and the ONDCP. The most recent court decision rejected the government's motion to dismiss, which allowed discovery to move forward. The American Civil Liberties Union hailed the decision as "a first-of-its-kind ruling."[83]

More recently, the DEA has escalated its enforcement efforts on the recently proliferated Los Angeles area medical cannabis collectives. On July 25, 2007, the DEA raided the California Patients Group, Hollywood Compassionate Collective, and Natural Hybrid (NHI Caregivers) in Hollywood, California.[84] Earlier that day, the operators of those collectives participated in a press conference with LA City Council members announcing the city's intention to regulate the collectives and asking the DEA to halt raids on collectives while the City drafted regulations.[citation needed] The dispensary operator of Natural Hybrid (NHI Caregivers) was forced to close down the collective due to the tremendous loss caused by the DEA conducted joint task force raid against them.[citation needed]

Project Cassandra

edit

In 2008 the Special Operations part of the agency launched a multi-agency effort named Project Cassandra[85] to investigate Hezbollah for allegations of illicit drug trafficking and terrorist financing. The investigation identified an Iranian cell in the U.S. which worked in concert with a Lebanese bank called the Lebanese Canadian Bank to launder money using the purchase of used automobiles exported to Africa. Project Cassandra also identified hemispheric drug syndicates involved in cocaine trafficking in order to finance Hezbollah activities. The Department of Justice issued several sealed indictments but declined to seize, prosecute, extradite, or further investigate likely targets of these alleged foreign criminal activities operating in the United States due to White House diplomatic objectives involving the international nuclear agreement with Iran.[86] On December 22, 2017, the Attorney General Jeff Sessions ordered a review of prior cases in the project.[87]

DEA Museum

edit
Main article: Drug Enforcement Administration Museum and Visitors Center

In 1999, the DEA opened the Drug Enforcement Administration Museum in Arlington County, Virginia. The original permanent exhibit – Illegal Drugs in America: A Modern History – remains the museum's centerpiece. The exhibit features "the more than 150 year history of drugs and drug abuse and the DEA," including a considerable collection of drug paraphernalia and an image of a smiling drug vendor under the heading "Jimmy's Joint".[88]

edit

The DEA are commonly featured in crime drama films and TV, as both protagonists and antagonists.

See also

edit

References

edit
  1. ^ "Staffing and Budget". www.dea.gov. Archived from the original on April 8, 2022. Retrieved March 31, 2022.
  2. ^ a b Sernovitz, Daniel J. (September 12, 2018). "DEA commits to Pentagon City for another 15 years". Washington Business Journal. Retrieved June 24, 2023.
  3. ^ "DEA Leadership". www.dea.gov. Archived from the original on February 17, 2022. Retrieved February 17, 2022.
  4. ^ "The DEA Years" (PDF). www.dea.gov.
  5. ^ "Drug Enforcement Administration: Drug Abuse Prevention Service Award" (PDF). Learning for Life. Archived from the original (PDF) on October 20, 2016. Retrieved October 9, 2016.
  6. ^ "History of the DEA: 1970 – 1975". deamuseum.org DEA museum. Archived from the original on September 28, 2007. Retrieved April 30, 2007.
  7. ^ "Marijuana Timeline". Public Broadcasting Service. Archived from the original on July 9, 2014. Retrieved April 23, 2007.
  8. ^ Lampe, Joanna R. (January 19, 2023). "The Controlled Substances Act (CSA): A Legal Overview for the 118th Congress". Congressional Research Service. Retrieved May 11, 2024.
  9. ^ "DEA History Book, 1985–1990". United States Department of Justice. Archived from the original on June 22, 2008. Retrieved August 31, 2011.
  10. ^ Michel, Lou; Herbeck, Dan (2001). American Terrorist. HarperCollins. ISBN 9780060394073.
  11. ^ Smith, Joseph (2002). "Anti-Terrorism: Criteria, Tools & Technology" (PDF). Protective Glazing. Applied Research Associates, Inc. Archived from the original (PDF) on September 18, 2013. Retrieved October 1, 2014.
  12. ^ "The DEA museum | Cannabis Culture Magazine". Cannabisculture.com. December 15, 2009. Archived from the original on January 19, 2012. Retrieved August 31, 2011.
  13. ^ "1999–2003". DEA. Archived from the original on May 26, 2007. Retrieved June 3, 2007.
  14. ^ "Title 28, C.F.R., Part 0.102" (PDF). Department of Justice. p. 57. Archived from the original (PDF) on August 10, 2007. Retrieved April 28, 2007.
  15. ^ "Divisions". Drug Enforcement Administration. 2024. Retrieved February 21, 2024.
  16. ^ Sernovitz, Daniel J. (December 22, 2015). "GSA seeking new headquarters for the DEA in Northern Virginia". Washington Business Journal . Retrieved June 24, 2023.
  17. ^ Sernovitz, Daniel J. (August 24, 2018). "The DEA wants to stay in Pentagon City. Now, a federal judge has weighed in". Washington Business Journal . Retrieved June 24, 2023.
  18. ^ "DEA - ONSI Presidential Policy Directive #28". acrobat.adobe.com. Archived from the original on July 13, 2022. Retrieved March 31, 2022.
  19. ^ "Top Careers for Students of Criminology and Criminal Justice". Portland State University. Archived from the original on October 19, 2014. Retrieved September 30, 2014.
  20. ^ "Drug Questionnaire". U.S. Drug Enforcement Administration. Archived from the original on May 13, 2007. Retrieved April 28, 2007.
  21. ^ "FBI may relax hiring policy on drug use". NBC News. October 9, 2005. Archived from the original on September 24, 2020. Retrieved August 31, 2011.
  22. ^ "Inside the DEA > DEA Programs > Aviation". U.S. Drug Enforcement Administration. Archived from the original on September 20, 2008. Retrieved September 13, 2008.
  23. ^ John Shiffman (August 5, 2013). "How DEA program differs from recent NSA revelations". Reuters. Archived from the original on March 12, 2016. Retrieved August 5, 2013.
  24. ^ "DEA / Cannabis Eradication". www.dea.gov. Archived from the original on April 5, 2018. Retrieved June 7, 2017.
  25. ^ "DEA / Cannabis Eradication". www.dea.gov. Archived from the original on April 5, 2018. Retrieved June 8, 2017.
  26. ^ "Analysis | The DEA spent $73,000 to eradicate marijuana plants in Utah. It didn't find any". The Washington Post. Archived from the original on June 23, 2017. Retrieved June 7, 2017.
  27. ^ "U.S. Department of Justice Drug Enforcement Administration - FY 2016 Performance Budget Congressional Submission" (PDF). www.justice.gov. Archived (PDF) from the original on May 6, 2017. Retrieved June 7, 2017.
  28. ^ "Congress Wants the DEA to Prove Marijuana Eradication Program Is Necessary". Congressman Ted Lieu. October 28, 2016. Archived from the original on August 30, 2017. Retrieved June 7, 2017.
  29. ^ "FY budget request". www.justice.gov. 2019. Archived from the original on November 3, 2018. Retrieved July 30, 2019.
  30. ^ "Drug Enforcement Administration Highlights Year's Accomplishments". dea.gov. December 28, 2005. Archived from the original on June 27, 2006. Retrieved April 28, 2007.
  31. ^ "What America's Users Spend on Illegal Drugs 1988–1998". Office of National Drug Control Policy. December 2000. Archived from the original on March 12, 2007. Retrieved April 28, 2007.
  32. ^ "News from DEA, News Releases, 12/11/08". Usdoj.gov. Archived from the original on August 21, 2009. Retrieved August 31, 2011.
  33. ^ Figure 4 Source: ONDCP. 1998 National Drug Control Strategy. Table 20.
  34. ^ Figure 5 Source: ONDCP. 1998 National Drug Control Strategy. Table 20.
  35. ^ Robinson, Matthew B.; Scherlen, Renee G. (March 10, 2010). Lies, Damn Lies and Drug War Statistics. State University of New York Press. ISBN 9780791480670. Archived from the original on April 16, 2021. Retrieved August 31, 2011.
  36. ^ "U.S. Department of Justice National Drug Intelligence Center (NDIC)". www.justice.gov. Archived from the original on August 31, 2009.
  37. ^ O’Donnell, Julie; Tanz, Lauren J.; Gladden, R. Matt; Davis, Nicole L.; Bitting, Jessica (December 17, 2021). "Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls — United States, 2019–2020". MMWR. Morbidity and Mortality Weekly Report. 70 (50): 1740–1746. doi:10.15585/mmwr.mm7050e3. ISSN 0149-2195. PMC 8675656. PMID 34914673.
  38. ^ Leana S Wen, Nakisa B Sadeghi (October 06, 2020). The opioid crisis and the 2020 US election: crossroads for a national epidemic Archived December 16, 2020, at the Wayback Machine The Lancet. VOLUME 396, ISSUE 10259, P1316-1318. DOI:https://doi.org/10.1016/S0140-6736(20)32113-9 Archived July 13, 2022, at the Wayback Machine. Retrieved 18 December 2020.
  39. ^ "24 MDMA, Chorles S. Grob and Russell E Polond". Drugtext.org. Archived from the original on September 11, 2011. Retrieved August 31, 2011.
  40. ^ Video Documentary: "Hooked – Illegal Drugs and How They Got That Way: LSD, Ecstasy and Raves", The History Channel
  41. ^ "Documents from the DEA Scheduling Hearing of MDMA, 1984-1988". MAPS. Archived from the original on May 23, 2012. Retrieved September 9, 2008.
  42. ^ Blumenson, Eric D.; Nilsen, Eva S. (January 29, 2007). "Policing for Profit: The Drug War's Hidden Economic Agenda". SSRN 959869.
  43. ^ "DEA's prescriber registration fees will increase Oct. 1". Archived from the original on October 18, 2020. Retrieved October 16, 2020.
  44. ^ a b c "Crimes by ATF and DEA informants not tracked by feds". USA Today. October 7, 2012.
  45. ^ "DEA Staffing & Budget". Justice.gov. Archived from the original on January 3, 2015. Retrieved December 18, 2014.
  46. ^ Boaz, David; Timothy Lynch (August 12, 2004). "The war on drugs" (PDF). Cato Handbook on Policy. Cato Institute. pp. 253–260. Archived from the original (PDF) on April 15, 2007. Retrieved May 3, 2007.
  47. ^ Libertarian Party (July 11, 2018). "LIBERTARIAN PARTY PLATFORM". Archived from the original on September 5, 2012. Retrieved January 14, 2016.
  48. ^ "Mission and Vision | Drug Policy Alliance". www.drugpolicy.org. Archived from the original on April 4, 2007. Retrieved May 3, 2007.
  49. ^ "News from DEA, News Releases, 02/10/99". Usdoj.gov. Archived from the original on October 21, 2008. Retrieved August 31, 2011.
  50. ^ "DEA, Drug Scheduling". Usdoj.gov. Archived from the original on October 20, 2008. Retrieved August 31, 2011.
  51. ^ "Student's ordeal: How was Daniel Chong lost in DEA detention?", MSNBC, May 4, 2012
  52. ^ "California Man’s ‘Drug Holiday’ Becomes Four-Day Nightmare in Holding Cell" Archived 2017-03-10 at the Wayback Machine, New York Times, May 2, 2012
  53. ^ Watson, Julie, and Freking, Kevin, "Federal lawmaker: DEA debacle suggests breakdown" Archived 2012-05-03 at the Wayback Machine, San Francisco Chronicle, May 3, 2012
  54. ^ Stan Wilson, Daniel Chong, forgotten in DEA cell, settles suit for $4.1 million Archived 2018-12-29 at the Wayback Machine, CNN (July 30, 2013).
  55. ^ a b c d Carter, Terry (August 12, 2013). "Sweeping reversal of the War on Drugs announced by Atty General Holder". ABA's 560-member policy making House of Delegates. American Bar Association. p. 1. Archived from the original on September 29, 2017. Retrieved August 16, 2013.
  56. ^ a b c d "Smart on Crime: Reforming The Criminal Justice System" (PDF). Remarks to American Bar Association’s Annual Convention in San Francisco, CA. US Department of Justice. August 12, 2013. p. 7. Archived (PDF) from the original on January 9, 2016. Retrieved August 16, 2013.
  57. ^ "HM announces measures to enhance security" (Press release). Press Information Bureau (Government of India). December 11, 2008. Archived from the original on December 25, 2018. Retrieved December 14, 2008.
  58. ^ a b Stevens, Andrew; Kapur, Mallika; Shah Singh, Harmeet; Ahmed, Saeed; Sidner, Sara; Vinci, Alessio; Sayah, Reza; Newton, Paula (November 29, 2008). "Indian official: Terrorists wanted to kill 5,000". CNN. Archived from the original on December 2, 2008. Retrieved November 30, 2008.
  59. ^ "Indian forces storm Jewish centre". BBC News. November 27, 2008. Archived from the original on November 28, 2008. Retrieved November 27, 2008.
  60. ^ "One Japanese killed, another wounded in Mumbai shootings". Channel NewsAsia. Retrieved November 26, 2008.[dead link]
  61. ^ P.S. Suryanarayana (November 27, 2008). "Caught in the crossfire, 9 foreign nationals killed". The Hindu. Chennai, India. Archived from the original on August 13, 2011. Retrieved November 27, 2008.
  62. ^ Krishnakumar P; Vicky Nanjappa (November 30, 2008). "Rediff: Doctors shocked at hostages's torture". Rediff.com. Archived from the original on March 5, 2009. Retrieved February 21, 2009.
  63. ^ Naughton, Philippe (November 27, 2008). "British yachting tycoon Andreas Liveras killed in Bombay terror attacks". The Times. UK. Archived from the original on July 13, 2022. Retrieved November 27, 2008.
  64. ^ "Three top cops die on duty". The Times of India. India. November 27, 2008. Archived from the original on July 25, 2019. Retrieved November 27, 2008.
  65. ^ "Indian victims include financier, journalist, actor's sister, police". CNN. November 30, 2008. Archived from the original on December 2, 2008. Retrieved November 30, 2008.
  66. ^ Christopher Toothaker. "Venezuela rejects U.S. drug report, accuses DEA of collaborating with traffickers". New County Times. Archived from the original on September 29, 2007. Retrieved March 2, 2007.
  67. ^ Webb, Gary (1999). Dark Alliance. Seven Stories Press. p. 177. ISBN 978-1-888363-93-7.
  68. ^ "Morales: Government will take over for DEA in Bolivia". CNN. November 1, 2008. Archived from the original on October 5, 2012. Retrieved November 2, 2012.
  69. ^ "Bolivia's Morales insists no return for US drug agency". BBC. November 8, 2011. Archived from the original on November 12, 2012. Retrieved November 2, 2012.
  70. ^ de Vries, Peter R. (October 2, 2005). "Dossier: De zwarte Cobra". Programma (in Dutch). Archived from the original on September 27, 2007. Retrieved May 12, 2007.
  71. ^ Goodman, Joshua; Mustian, Jim (February 1, 2024). "Secret US spying program targeted top Venezuelan officials, flouting international law". AP News. Retrieved February 4, 2024.
  72. ^ "La DEA, la Fiscalía y un coronel entramparon el proceso de paz | Cambio Colombia".
  73. ^ Shiffman, John; Cooke, Kristina (August 5, 2013). "Exclusive: U.S. directs agents to cover up program used to investigate Americans". Reuters. Archived from the original on August 14, 2013. Retrieved June 2, 2016.
  74. ^ O'Hehir, Andrew (August 10, 2013). "The NSA-DEA police state tango". Salon. Archived from the original on June 22, 2016. Retrieved June 2, 2016.
  75. ^ "The DEA: Four Decades of Impeding And Rejecting Science". DPA, MAPS. Archived from the original on June 13, 2014. Retrieved June 14, 2014.
  76. ^ Grotenhermen, F; Müller-Vahl, K (July 2012). "The therapeutic potential of cannabis and cannabinoids". Deutsches Ärzteblatt International. 109 (29–30): 495–501. doi:10.3238/arztebl.2012.0495. PMC 3442177. PMID 23008748.
  77. ^ Pamplona, FA; Takahashi, RN (January 2012). "Psychopharmacology of the endocannabinoids: far beyond anandamide". Journal of Psychopharmacology. 26 (1): 7–22. doi:10.1177/0269881111405357. PMID 21652605. S2CID 4000916.
  78. ^ Adler, Jonathan N.; Colbert, James A. (May 30, 2013). "Medicinal Use of Marijuana — Polling Results". New England Journal of Medicine. 368 (22): e30. doi:10.1056/NEJMclde1305159. PMID 23718175.
  79. ^ "Feds Raid 11 Medical Marijuana Clinics, DEA Does Not Recognize California Law legalizing the medical use of pot". CBS News. Archived from the original on May 18, 2013. Retrieved August 31, 2011.
  80. ^ Rough, Lisa (November 18, 2015). "Petition to Fire DEA Chief Gains Traction". Leafly. Archived from the original on April 16, 2021. Retrieved June 12, 2017.
  81. ^ "Feature: Move to Block DEA Medical Marijuana Raids Heads for House Floor Vote Next Week". Stopthedrugwar.org. Archived from the original on June 29, 2011. Retrieved August 31, 2011.
  82. ^ "Santa Cruz officials fume over medical pot club bust / DEA arrests founders, confiscates plants". San Francisco Chronicle. September 6, 2002. Archived from the original on January 3, 2009. Retrieved August 31, 2011.
  83. ^ "Federal Court Rules U.S. Government May Not Deliberately Subvert California's Medical Marijuana Laws". American Civil Liberties Union. August 20, 2008. Archived from the original on October 25, 2009. Retrieved August 31, 2011.
  84. ^ Lee, Martin (2012). "An Industry Emerges: The Rise of Medical Marijuana". Reality Sandwich. Archived from the original on October 6, 2014. Retrieved October 1, 2014.
  85. ^ Meyer, Josh. (18 December 2017). "The secret backstory of how Obama let Hezbollah off the hook". Politico website Archived December 17, 2017, at the Wayback Machine Retrieved 24 December 2017.
  86. ^ Meyer, 2017
  87. ^ Hacohen, Hagay and Wilner, Michael. (23 December 2017). "Sessions Orders a Review of Project Cassandra". Jerusalem Post website Archived December 25, 2017, at the Wayback Machine Retrieved 25 December 2017.
  88. ^ "Illegal Drugs in America, a Modern History". DEA Museum Website. Archived from the original on October 24, 2011. Retrieved February 27, 2012.

Further reading

edit
edit
 
Wikimedia Commons has media related to Drug Enforcement Administration.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Drug_Enforcement_Administration&oldid=1255964833"